Nasdaq Stockholm AB: Delisting of Karessa Pharma Holding AB (publ) from Nasdaq First North Growth Market (94/20)

On February 10, 2020, Nasdaq Stockholm AB announced that it had approved an
application from Karessa Pharma Holding AB (publ) (the "Company") to delist the
Company's shares from Nasdaq First North Growth Market, conditional upon the
Swedish Companies Registration Office's authorization to implement a merger
plan between the Company and Klaria Pharma Holding AB (publ). 

Today, March 2, 2020, the Swedish Companies Registration Office granted the
companies concerned authorization to implement the merger plan in question. 

Accordingly and as previously announced, the last day of trading in the shares
of Karessa Pharma Holding AB (publ) will be today, March 2, 2020. 

Short name:     KARE        
----------------------------
ISIN code:      SE0005506193
----------------------------
Order book ID:  106031      
----------------------------


For further information concerning this exchange notice please contact Issuer
Surveillance, telephone [phone], or [e-mail].